Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...

Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant ...

Rather, I was suggesting that he use the metaphor of promiscuous enzymes, a concept I’d learned from Andreas Wagner’s ...

Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency ...

Medical education faces challenges. Time is scarce. Resources are tight. Information overload is real. But by delivering ...